Join us for a captivating panel discussion, Innovation without Borders: How the
Immigrant Mindset has Helped Power the Biotech Industry in the US, featuring
stakeholders from the biotech ecosystem bringing a wealth of experience and
insights into the intersection of immigration, innovation, and biotechnology.

In this thought-provoking discussion, we will delve into the impact of immigrant
entrepreneurs and professionals on driving innovation within the biotech sector.
From their unique perspectives to their unwavering determination, driven by a
beginner’s mindset and survival instincts, immigrants have played a pivotal role in
shaping the landscape of biotechnology in the United States.

Join us as we explore the fascinating stories and the success strategies behind
some of the most groundbreaking advancements in biotech, fueled by the
immigrant mindset. Discover how diversity of thought, cultural richness, and
global perspectives have contributed to this and gain valuable insights into the
future of innovation without borders.

Don't miss this opportunity to gather inspiration and key take aways that can be
applied universally. Reserve your spot for an evening of enlightening conversation
and visionary thinking.

Julien L. Pham

Julien L. Pham, MD, MPH, is Founder and Managing Partner of 3CC | Third Culture Capital, an immigrant-founded, physician-led, and diversity-certified seed-stage VC firm focused on emerging healthtech and techbio companies that are revolutionizing modern care delivery while optimizing and reshaping the experience of care for both patients and providers.

Dr. Pham has over 15 years of leadership experience in clinical settings and in emerging medical technology companies, including over a decade as a serial healthcare entrepreneur. He is a “Third Culture” individual who, by the age of 15, experienced 3 different cultures, growing up on 3 continents. This has deeply influenced his and 3CC’s ethos around diversity, equity, and purpose. 3CC’s mission is to change the face of healthcare innovation by backing founders with diverse backgrounds and experiences.

Noor Jailkhani

Noor Jailkhani, Ph.D, is the CEO and co-founder of Matrisome Bio, a targeted therapy platform focused on developing breakthrough therapies and improving the lives of patients with chronic diseases such as cancer and fibrosis. As the founding CEO, Noor has led the company since its inception, successfully securing seed funding from venture investors and steering the company’s strategic vision.

Avak Kahvejian

Avak Kahvejian, Ph.D. is a life sciences inventor, entrepreneur, and CEO who has co- founded more than ten companies. Since 2011, he has been a partner at Flagship Pioneering, where he leads a team to invent and launch new therapeutic platforms. His work has led to the creation of multiple high-value public and private companies.

Heike Keilhack

An accomplished scientist with rich experience in cell biology, animal models of cancer and inflammation, pharmacology and translational medicine with over 20 years of experience in drug discovery in both small biotechnology companies and large pharmaceutical companies.

Jonathan Thon

Jonathan Thon, Ph.D, a Serial Biotech Entrepreneur, accomplished CEO, and experienced Board Member with technical expertise in cell & gene therapy, hematology, and cell culture/manufacturing who specializes in founding and leading startups through company formation, discovery, and pre/clinical development.